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Abstract
Background: In young patients with osteonecrosis of the femoral head (ONFH), short-stem total hip arthroplasty
(THA) could allow a potential advantage in preserving metaphyseal bone-stock, when revision surgery might
become necessary. However, only a few studies have evaluated the outcome of short-stem THAs in ONFH. We
reviewed the prospectively collected data of a cementless partial neck-retaining short-stem with ceramic-on-
ceramic bearings in ONFH patients.
Methods: Thirty patients (37 hips) younger than 60 years (mean age at surgery, 51.5 years) underwent THA with the
NANOS® stem (Smith and Nephew, Marl, Germany) from January 2006 to December 2012. All patients received a
32-mm or 36 mm ceramic femoral head. Harris hip score, WOMAC and UCLA activity score were recorded.
Postoperative radiographs were evaluated for bone-implant fixation and osteolysis. Further analysis correlated clinical
findings with implants characteristics and patient demographics at mean 5.6 years’ follow-up (range, 3–10 years).
Results: The clinical and functional results improved significantly (p < 0.001). At latest follow-up, mean HHS, WOMAC,
and UCLA activity scores were 90 (range, 71–100), 94 (range, 76–100), and 6.3 (range, 4–10) points, respectively.
The diameter of the femoral head did not influence the clinical outcome (p = 0.661). All hips showed bone ingrowth
fixation of the acetabular and femoral components. No patients showed osteolysis. No revision for any reason was
performed during the study period.
Conclusions: The excellent clinical results and fixation pattern at mean 5.6 years’ follow-up reveal this implant as a
reliable option in advanced stage of ONFH either. Further investigations are crucial to determine the long-term
durability and to assess whether the association of ceramic-on-ceramic bearings, can be useful to achieve longer
survivorship and lower complications rates.
Trial registration: Registry number: ISRCTN 91336248; date of registration: 04/07/2017.
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Background
Osteonecrosis of the femoral head (ONFH) is a complex
syndrome in which a localized area of bone becomes nec-
rotic, primarily due to an impairment of its blood supply
[1]. With regard to non-traumatic ONFH, some of the
most common and well-described risk factors include
high dose corticosteroid use, chemotherapic and immuno-
suppressant agents, excessive alcohol consumption, and
smoking [2–7]. As stated by Mont et al. [8, 9], if
untreated ONFH unfortunately is often progressive.
Once irreversible collapse of the articular surface has
taken place, according to the existing literature, at-
tempts to preserve the femoral head are less success-
ful and better results are achieved through joint-
replacing techniques [1, 10–12]. Common joint-
replacement treatments include hip resurfacing, total
hip arthroplasty (THA) and short stem THA [13–18].
High failure and complications rates have been
reported for both hemi-resurfacing and total hip re-
surfacing [10, 13, 19, 20], therefore total hip resur-
facing is now considered a valuable option only for
restricted indications [21, 22].
Historically, traditional THAs performed on patients
with ONFH were reported to have lower survivorship and
worse outcomes when compared to THAs performed for
other diagnoses, with a failure rate ranging from 39% to
53%, in first generation hip arthroplasty [23–25]. A sys-
tematic literature review, showed a significant decrease in
revision rates in patients who had surgery in 1990 or later,
versus those who underwent surgery before 1990, with
revision surgery performed or indicated in 17% (0–50%)
and 3% (range 0–7%) of hips respectively [26]. This trend
was confirmed in recent reviews that showed survivor-
ship higher than 90% and remarkable improvements in
clinical outcomes of contemporary cementless THAs
performed for ONFH, due to major advances in the
production techniques of implants, in bearing coupling
and improved polyethylene sterilization and storage
[27, 28].
Even though according to the literature traditional
stems showed to be a reliable option in ONFH, due to
the younger age of patients, short-stem arthroplasty
could allow a potential advantage in metaphyseal bone
stock preserving, when revision surgery might become
necessary [6, 29]. A number of different short-stem
designs have been developed [12]. Unfortunately, there
are only few studies presenting the clinical outcome of
short-stem THAs in ONFH [16–18].
Based on these considerations, we reviewed the pro-
spectively collected data of a partial neck-retaining short
stem and ceramic-on-ceramic bearings in patients youn-
ger than 60 years with progressed ONFH. The aim of the
study is to assess the clinical and radiological outcome at
mid – term follow up.
Methods
From January 2006 to December 2012, a partial neck-
retaining cementless femoral short-stem was used for 39
THAs in 32 patients 60 years of age or younger, due to
osteonecrosis of the femoral head; 7 patients (21.87%) had
bilateral THAs. Patients were excluded from the study if
they were older than 60 years or had a follow up of less
than 3 years after the operation. Two patients were lost to
follow-up in the interim, meaning that 30 patients (37
hips, 94.87%) were available for clinical and radiographic
evaluation at a mean follow-up of 5.6 years (range, 3–
10 years). During the study period, in our institution 24
THAs (20 patients) due to ONFH were performed by the
senior author (AC) using other implants in patients older
than 60 years of age. The study was approved by the Insti-
tution review board, and all patients provided written in-
formed consent. The mean age of the patients at the time
of the index arthroplasties was 51.5 years (range, 27–
60 years). There were 31 men and 1 women. According to
ONFH Steinberg Classification, 19 hips were Stage IV
(51.35%) and 18 were Stage V (48.64%) [30]. The morph-
ology of the proximal femur was Dorr [31] Type A in 21
hips (56.75%) and Type B in 16 hips (43.25%). The pre-
sumed cause of osteonecrosis was idiopathic osteonecrosis
in 28 hips (75.67%), corticosteroid use for seronegative
rheumatic disease in 5 (13.51%), pharmacological treat-
ment for leukemia/lymphoma in 4 (10.81%) (Table 1).
All patients received a partial neck-retaining short-stem
(NANOS®; Smith and Nephew, Marl, Germany). The
implant consisted of a titanium alloy stem with a calcium-
phosphate coating on approximately 75% of the stem
(BONIT®; DOT GmbH, Germany). A 32- or 36-mm
diameter ceramic femoral head (BIOLOX-forte; CeramTec,
Plochingen, Germany) was implanted in 13 hips and 24
hips, respectively. A cementless porous-coated acetabular
shell (EP-FIT PLUS™; Smith and Nephew, Marl, Germany),
Table 1 Demographic data of patients
Demographic Number
Number of patients (hips) 30 (37)
Male:female 29:1
Mean age (years) 51.5 (27–61)
Right:left side 18:19
Diagnosis (hips): Osteonecrosis
Idiopathic 28 (75.68%)
Seronegative rheumatic disease 5 (13.52%)
Leukemia-Limphoma 4 (10.80%)
Steinberg stage
IV 19 (51.35%)
V 18 (48.65%)
Duration of follow-up (years) 5.6 (3–10)
Ranges or percentages in parentheses
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was used in all hips, ranging from 46 to 58 mm. A ceramic
liner (BIOLOX-forte; CeramTec, Plochingen, Germany)
was used in all hips. All procedures were performed by the
senior author (AC) through a modified Hardinge approach,
in supine position. The index operation was performed
under epidural anesthesia in all 32 patients. After femoral
head resection, at least 10 mm from the base of the great
trochanter and perpendicular to the femoral neck, the fem-
oral path was prepared with cancellous bone compactors.
The stem was then inserted with a press-fit technique. In
all cases, the acetabulum was reamed line-to-line or 1 mm
more than the diameter of the component used. The pa-
tients were allowed to stand on the first postoperative day
and progress to full weight-bearing with crutches. Patients
were recommended to use a pair of crutches for 4 weeks.
Clinical and radiographic follow-up was performed at
1 months, 3 months, 6 months, 1 year, and yearly there-
after. The Harris hip score (HHS) [32], the Western On-
tario and McMaster Universities Osteoarthritis Index
(WOMAC) [33] and the UCLA score [34] were determined
before surgery and at each follow up examination. Patients
were asked about thigh pain. The evidence of any clicking
or squeaking sound emanating from the ceramic-on-
ceramic bearing was recorded. Radiographs were analyzed
by a research fellow (GM) who had no knowledge of the
patient’s identity. An anterior-posterior radiograph of the
pelvis with both hips in slight neutral rotation and no
abduction was taken for every patient. A frog-leg lateral
radiograph was also made of each hip. To measure the in-
clination of the acetabular component a line that joined the
inferior margins of the two acetabular teardrops on the AP
pelvic radiograph was drawn (inter-teardrop line), and then
the angle of abduction was determined by the intersection
line marked through the plane of opening of the socket.
The level of neck osteotomy was considered correct when
performed at least at 10 mm from the great trochanter.
Stem position was considered varus or valgus when the tip
of the stem slightly touched the medial or lateral cortical,
respectively. The modification of the acetabular center of
rotation was determined by radiographic measurements of
the distance between the hip center of rotation and one
horizontal and one vertical reference line [35]. The femoral
offset measurements were performed by calculating the
horizontal distance between the center of rotation and the
femoral anatomical axis [36]. Leg length discrepancy (LLD)
was investigated as the difference between the distances
from the inter-teardrop line and the tip of the lesser tro-
chanter of both hips. The stability of the acetabular compo-
nent was determined according to Manley criteria [37].
Any site of acetabular osteolysis was recorded according to
the system of DeLee and Charnley [38] and migration was
assessed as described by Massin et al. [35]. Femoral stem
fixation was investigated for bone ingrowth, stable fibrous
fixation or unstable fibrous fixation according to Engh [39].
Subsidence was investigated as described previously by Kim
[40]. Loosening of the femoral component was defined
when there was a progressive axial of more than 3 mm or a
varus or a valgus shift of more than 3° [40]. Osteolysis was
defined as any radiolucency line at the bone-prosthesis
interface according to the seven zones of Gruen [41]. Prox-
imal femoral stress shielding and bone resorption was
graded radiographically, as described by Engh et al. [42].
Heterotopic ossification, if present, was graded according to
the classification of Brooker [43].
Statistical analysis
The changes in clinical scores between pre-surgery and
follow-up were evaluated using paired t-test. Analysis of
covariance (ANCOVA) models including the pre-surgery
values were used to assess the effect of Steinberg class (IV vs.
V), diagnosis (idiopathic vs. secondary) and head size (32- vs.
36-mm) on the changes in clinical scores and radiographic
data. For all analyses, a confidence interval level of 95% was
selected and statistical significance has been set at p values of
<0.001. Statistical analysis was performed using SAS Software
Version 9.4. (SAS Institute Inc., Cary, NC, USA).
Results
A statistically significant clinical and functional improve-
ment was observed in HHS, WOMAC, and UCLA activity
scores (Table 2).
The preoperative UCLA activity score was 2.9 points
(range, 2–4 points), which improved to 6.3 points (range, 4–
10 points) at the final follow up. This improvement was sta-
tistically significant (p < 0.001). 23 patients (76.6%) referred
that regularly participate in active events such as bicycling,
bowling and 10 (30%) of these patients sometimes partici-
pate in impact sports such as jogging, tennis and skiing.
All patients were able to stop using the cane within
3 months. At the final follow-up (range 3–10 years),
three patients had fair results at HHS. Two of these pa-
tients had a mild limp related to abductor mechanism
deficiency. The other one developed ONFH of the non-
operated hip. No patient complained thigh pain.
No statistically significant difference in the mean follow-
up scores for HHS (p = 0.588), WOMAC (p = 0.104) and
UCLA activity score (p = 0.753) was found between the
idiopathic ONFH group and secondary ONFH group. The
mean follow-up scores were similar for HHS (p = 0.747),
WOMAC (p = 0.541), UCLA activity score (p = 0.787) in
the Steinberg stage V group and in Steinberg stage IV group.
No statistically significant difference in the mean follow-
up scores for HHS (p = 0.022), WOMAC (p = 0.661) and
UCLA activity score (p = 0.363) was found between the
32-mm alumina head group and 36-mm group. No statis-
tically significant difference in complication rates between
the two groups was found (p = 0.567). One patient (2.70%
of hips) in the 36-mm group had early dislocation that
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was successfully treated with closed reduction. An other
patient (2.70% of hips) in the 36-mm group had clicking
sounds without evidence of alumina head or liner fracture,
and no squeaking was detected.
At postoperative plain radiographs, stem position was
neutral in 33 (89.18%) cases, valgus in 2 (5.40%) and varus
in 2 (5.40%). The acetabular inclination between 40° to 50°
(mean value 47°; range, 44°-52°) was obtained in 38 hips
(97.43%). Osseointegration was complete for all hips at
minimum 3-year follow-up, as confirmed by radiographic
signs of fixation and the absence of stem migration. No
hip had a subsidence of more than 3.0 mm or 3°shift in
varus/valgus. 9 hips (24.32%) exhibited Grade 1 stress
shielding in the calcar region and 1 (2.70%) had Grade 2.
No acetabular or femoral osteolysis was identified in any
hip. Grade 1 heterotopic ossification occurred in 5 hips
(13.51%) (Table 3). No hip had revision or aseptic loosen-
ing at mean 5.6-years follow-up (range 3–10) (Fig. 1).
Discussion
Early reports on THAs showed unsatisfactory results in
patients with ONFH [23–25]. However, the incidence of
THAs performed in ONFH has increased dramatically
according to the analysis of an USA nationwide sample
performed by Mont et al.: the proportion of ONFH
treated with THA increased from 75% in 1992 to 88% in
2008. On the other hand, the proportion of joint-
preserving procedures decreased from 25% to 12% [44].
Moreover, recent literature suggests a marked improve-
ment in the survivorship and outcomes of THA when per-
formed in ONFH population [27, 45–47]. There are only
few studies presenting the clinical outcome of short stem
THAs in ONFH at mid-term follow up. We therefore
evaluated a series of patients 60 years old or younger who
received a partial neck-retaining femoral short-stem with
ceramic - on - ceramic bearings to determine mid-term
clinical and functional results using validated scoring
instruments.
The mid – term results in our series showed good to ex-
cellent clinical outcome and pain relief. At latest follow-up,
mean HHS, WOMAC and UCLA activity scores were 90
(range, 71–100), 94 (range, 76–100), and 6.3 (range, 4–10)
points(p < 0.001), respectively. Furthermore, there were no
Table 2 Clinical results
Preoperative Follow-up at 5.6 years p value (Student’s two tailed paired test)
Harris hip score (points) 53 (range, 35–67) 90 (range, 71–100) <0.001
Excellent (90–100) 0 34 (91.9%) -
Good (80–89) 0 0 -
Fair (70–79) 0 3 (8.1%) -
Poor (<70) 37 (100.0%) -
WOMAC score (points) 53 (range, 40–67) 94 (range, 76–100) <0.001
UCLA activity score (points) 2.9 (range, 2–4) 6.3 (range, 4–10) <0.001
Thigh pain - None -
Clicking Sound - 1 (2.56%) -
Squeaking sound - None -
Values are expressed as mean, with range or percentages in parentheses
Table 3 Radiographic results
Parameter Number
Dorr bone type
A 21 hips (56.75%)
B 16 hips (43.25%)
Acetabular component position
Inclination 47.0° (44° - 52°)
Femoral component position
Neutral 33 hips (89.18%)
Valgus 2 hips (5.40%)
Varus 2 hips (5.40%)
Level of osteotomy (mm) 13.85 (10–20)
Center of rotation
Horizontal (mm) 38 ± 4.5 (30–46)
Vertical (mm) 17.3 ± 4.2 (11–26)
Femoral offset (mm) 46 ± 4.7 (38–56)
Limb-length (mm) 37.4 ± 3.65 (28–45)
Radiolucent line (>1 mm) 0 hip (0.00%)
Migration of acetabular or femoral component 0 hip (0.00%)
Stress shielding
Grade 1 9 hips (24.32%)
Grade 2 1 hip (2.70%)
No 27 hips (72.97%)
Osteolysis 0 hip (0.00%)
Heterotopic ossification
Grade 1 5 hips (13.51%)
No 32 hips (86.49%)
Ranges or percentages in parentheses
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radiographic evidence of osteolysis and no need for revi-
sion. Our results are similar to the majority of reports by
other researchers using cementless short-stem THAs in
ONFH [16, 18, 48–51] (Table 4).
Floerkemeier et al. reported data of the Metha short-stem
arthroplasty [18] in 73 patients who suffered from second-
ary osteoarthritis due to ONFH. At 3 years mean HHS
score was 90,4 and no complication occurred during the
follow-up. Zeh et al. [16] compared the midterm results of
the MAYO short-stem THA in ONFH and in primary cox-
arthritis. After implantation of 26 Mayo short stem THAs
in 21 patients, in the study group the postoperative HHS
was 93.5 compared to 94.2 in the control group at 7.9 years
mean follow - up. Recently, Jerosch et al. [48] reviewed the
results of the MiniHip short-stem arthroplasty in 18 osteo-
necrotic hips. Hip Dysfunction Osteoarthritis and Outcome
Score (HOOS) improved from 44.4 to 96.2 points at 4-year
mean follow - up.
Moreover, our results are consistent even with clinical
and radiological outcomes of standard stems arthroplasties
due to ONFH [52, 53]. In a recent study, with mean follow-
up time comparable to our series, Gao et al. [52] recruited
21 patients, 6 with bilateral necrosis (27 hips). A cementless
standard stem was used in all hips and they reported a final
follow-up mean HHS of 88.6 (p < 0.001). Cheung et al. [53]
reported long-term results of a hydroxyapatite coated
cementless femoral stem used in 117 total hip arthroplas-
ties due to ONFH. At a mean follow-up of 14.7 years, HHS
improved from mean preoperative 35.6 points to mean
postoperative 83.8 (p < 0.001). Furthermore, they compared
these results with a non-.
ONFH patient group of 65 hips and they found no
statistically significant difference (p = 0.347).
Third generation ceramic bearings, according to pub-
lished data allow low wear rates with the supposed benefit
of remarkable long term survival even in young and active
patients [54, 55]. Our results were comparable to those in
other reports of THA using third-generation ceramic
bearings in patients with osteonecrosis of the femoral
head [56–61] (Table 5).
In our study, we did not found any evidence of squeaking
and detected only one case (2.7%) in which occurred a click-
ing sound, tolerated by the patient, without sign of liner
breaking or gross wear. As determined by previous studies
[62–64], we speculated that patients who received a 36 mm
head should have better function than 32 mm-head patients
group. Thus, in our series the differences in functional scores
between the two groups were not statistically relevant. Even
more, we had only one case of early dislocation which has
presented in a 36-mm head bearing. Similarly, Allen et al.
[65] stated their study failed to show that increasing femoral
head size significantly improves function 1 year after total
hip arthroplasty, but showed that the use of a 36 mm or
greater femoral head did reduce the dislocation rate. Lu et al.
Fig. 1 a-c Radiographs show the case of a 48-year-old male patient
who had osteonecrosis of both femoral heads. a AP view of the pelvis
before surgery shows Steinberg Stage IV osteonecrosis of the right
femoral head. b AP view of the pelvis taken 1 years postoperatively
reveals that acetabular and femoral components are well fixed in a
satisfactory position; the left hip shows Steinberg Stage V osteonecrosis
of the left femoral head. c At 7-year follow-up AP view Grade 1 calcar
resorption is evident in both hips, without signs of stem loosening
and osteolysis
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[66] found similar dislocation rates but better flexion in
≥36 mm group than in <36 mm group at 1–3 year after
surgery.
The main concern of the opponents of short-stems use
in ONFH is the theoretical increased risk of subsidence
due to poor bone quality of the proximal femur [16, 67].
However, the results of the 37 hips evaluated in this study
suggest that the concerns about poor secondary bone
ingrowth and potential early revision of short-stems are
possibly unfounded. In our series, osseointegration was
seen in all hips and no signs of stem migration and oste-
olysis were detected at plain radiographs analysis in any of
the 37 hips studied after a mean follow-up of 5.6 years.
Kaipel et al. [68] assessed migration data in 49 NANOS
short-stem arthroplasties, performed in patients affected
by coxarthritis and ONFH, using a computer-assisted
system. At 2-years follow-up, five (10%) stems showed
vertical migration of more than 1.5 mm, but just in one
case, distinctive subsidence could be monitored with
conventional X-rays and was probably caused by under-
sizing of the femoral implant. All other cases showing ver-
tical migration at the software analysis had no correlation
at the conventional X-rays and in clinical outcome.
This study has a number of limitations. Firstly, this is a
single surgeon’s case series and there is no control group.
The second limitation, is the length of the enrollment period
Table 4 Summary of studies regarding the outcome of partial neck-retaining short-stem total hip arthroplasty in patients with
osteonecrosis of the femoral head
Study Implant
name
Implant design Number
of THAs
Bearings Mean age
(years)
Mean follow
up (years)
Mean Postoperative
HHS
Stem revisions for
aseptic loosening
Floerkemeier
et al. [18]
Metha (B. Braun
Aesculap)
Partial collum with
neck preserving
osteotomy
73 Poly –
Ce
Ce - Ce
49.4 3 90.6 0
Jerosch
et al. [48]
Mini hip
(Corin)
Partial collum with
neck preserving
osteotomy
20 Ce - Ce 36.2 4 HOOS: 93.9 0
Kim
et al. [49]
Proxima
(Depuy)
Wedge femoral
neck-sparing
short stem
144 (88 THAs in
ONFH patients)
Ce - Ce 53.9 4.5 96 0
Wang
et al. [51]
CFP (Link) Modular femoral
neck-sparing
short stem
9 N/A 24.1 1.5 92.8 0
Zeh
et al. [16]
Mayo
(Zimmer)
Double-tapered
short stem
modular neck
26 N/A 44.9 7.9 93.5 0
Suksathien
et al. [50]
Metha (B. Braun
Aesculap)
Partial collum with
neck preserving
osteotomy
120 N/A 44.4 2.4 97.7 0
Current
study
NANOS (Smith
& Nephew)
Partial collum with
neck preserving
osteotomy
37 Ce - Ce 51.5 5.6 90 0
Table 5 Summary of studies regarding the outcome of ceramic bearings in patients with osteonecrosis of the femoral head
Study Number
of THAs
Mean age
(years)
Mean follow
up (years)
Head size Mean postoperative
HHS
Complications Survivorship
(endpoint)
Lim et al. [59] 53 49 5.3 32 mm in 11 hips
36 mm in 42 hips
97 noises 2/53 (4%)
1 squeaking
1 clicking
100% (revision)
Kim et al. [58] 93 38.2 11.1 28 mm 96 squeaking 2/93 (2%)
recurrent dislocation
1/93 (1%)
isolated dislocation
1/93 (1%)
99% (revision)
Millar et al. [60] 24 46 2,8 N/A 85.7 isolated dislocation
1/24 (1%)
N/A
Solarino et al. [61] 68 50 13 32 mm 90.7 N/A 95% (revision)
Evangelista et al. [57] 53 31 5.3 N/A 89 squeaking 3/53 (7%) 96.2% (revision)
Byun et al. [56] 56 25.6 7.7 N/A 98.2 squeaking 1/56 (2.4%) 100% (revision)
N/A not available
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and the small number of patients observed in the study.
Thirty - seven hips, for thirty study patients with a mini-
mum follow-up of three years are sufficient to detect early
stem migration but does not allow analyzing influencing fac-
tors for implant failure such as gender, age, or implant size.
Lastly, we did not use radiostereometric analysis to evaluate
for migration, and this could have led to a lack of accuracy
in radiographic measurements due to manual techniques.
Conclusions
In summary, this study shows beneficial radiological data
and excellent clinical mid-term results after the implantation
of a partial neck-retaining short-stem with ceramic-on-
ceramic bearings in ONFH patients. Based on the results of
the present study, the migration and fixation pattern at mean
5.6-years follow-up predicts that a partial-neck retaining
short stem could be a reliable option in advanced stage of
ONFH either. Further investigations are crucial to determine
the long-term durability of short stem THAs and to assess
whether the association of ceramic-on-ceramic bearings, can
be useful to achieve longer survivorship of the implants,
better functional results and lower complications rates.
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